logo
episode-header-image
Mar 2023
35m 2s

Journal Review in Colorectal Surgery: Lo...

Behind The Knife: The Surgery Podcast
About this episode
You have a patient who underwent local excision of a rectal cancer. Final pathology demonstrates a T2 lesion. What is the rate of local recurrence? Is excision alone sufficient? Should the patient undergo radical resection or should chemoradiation be offered? Tune in to find out!

Join Drs. Peter Marcello, Jonathan Abelson, Tess Aulet and special guest Dr. Jose Guillem MD, MPH, MBA as they discuss high yield papers discussing local excision for Rectal Cancer.

You may follow along with the slides mentioned in this episode here: https://behindtheknife.org/video/journal-review-in-colorectal-surgery-local-excision-for-rectal-cancer/

Learning Objectives
1. Describe the features that increase risk of lymph node involvement in early stage rectal cancer
2. Discuss the different options for management of early-stage rectal cancer
3. Describe patient related factors that favor local excision of rectal cancer

References:
Kidane B, Chadi SA, Kanters S, Colquhoun PH, Ott MC. Local resection compared with radical resection in the treatment of T1N0M0 rectal adenocarcinoma: a systematic review and meta-analysis. Dis Colon Rectum. 2015 Jan;58(1):122-40. doi: 10.1097/DCR.0000000000000293. PMID: 25489704.

Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, Thomas CR Jr, Chan E, Cataldo PA, Marcet JE, Medich DS, Johnson CS, Oommen SC, Wolff BG, Pigazzi A, McNevin SM, Pons RK, Bleday R. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol. 2015 Nov;16(15):1537-1546. doi: 10.1016/S1470-2045(15)00215-6. Epub 2015 Oct 22. PMID: 26474521; PMCID: PMC4984260.

Friel CM, Cromwell JW, Marra C, Madoff RD, Rothenberger DA, Garcia-Aguílar J. Salvage radical surgery after failed local excision for early rectal cancer. Dis Colon Rectum. 2002 Jul;45(7):875-9. doi: 10.1007/s10350-004-6320-z. PMID: 12130873.

Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum. 2002 Feb;45(2):200-6. doi: 10.1007/s10350-004-6147-7. PMID: 11852333.

O'Neill CH, Platz J, Moore JS, Callas PW, Cataldo PA. Transanal Endoscopic Microsurgery for Early Rectal Cancer: A Single-Center Experience. Dis Colon Rectum. 2017 Feb;60(2):152-160. doi: 10.1097/DCR.0000000000000764. PMID: 28059911.

 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  

If you liked this episode, check out other colorectal episodes here: https://behindtheknife.org/podcast-category/colorectal/
Up next
Oct 9
A Practical Approach to Understanding Global Surgery
In this kickoff episode of the Behind the Knife Global Surgery Series, we dive into what global surgery really means—and why it matters to all of us. Five billion people lack access to safe, timely, and affordable surgical care. Our guest, Dr. Juan Carlos Puyana, shares powerful ... Show More
28m 42s
Oct 6
Journal Review in Hepatobiliary Surgery: Resecting Perihilar Cholangiocarcinoma
Surgical resection of perihilar cholangiocarcinoma (pCCA) is one of the highest-risk elective operations performed. The obstructive jaundice suffered by patients preoperatively, central location of the tumors, and extensive nature of the resection make pCCA one of the most challe ... Show More
35m 35s
Oct 2
Clinical Challenges in Surgical Oncology: Pheochromocytomas
Join the Behind the Knife Surgical Oncology Team as we discuss the nuances in the work up and management of patients with pheochromocytomas. Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Scien ... Show More
28m 30s
Recommended Episodes
Dec 2022
Vom Bereuen einer radikalen Krebstherapie
mit Dr. med. Valentin Meissner, Urologe Die Patienten der Studie waren vor rund 20 Jahren an einem lokal begrenzten Prostatakarzinom erkrankt, und bei allen fiel die Therapieentscheidung zur radikalen Prostatektomie. Diese kann, wie fast jede Behandlung, mit unerwünschten Nebenwi ... Show More
22m 41s
May 2024
S2 Episode 1: Tumor Trash or Treasure? Liquid Biopsy for Colorectal Cancer
Are you using liquid biopsies in your practice? Join Drs Benjamin Schlechter and Pashtoon Kasi as they review the latest clinical applications of ctDNA and liquid biopsies in colorectal cancer. Relevant disclosures can be found with the episode show notes on Medscape https://www. ... Show More
27m 24s
Feb 2024
Advances in Precision Oncology for GI Cancers at GI24
Drs. Shaalan Beg and Rachna Shroff discuss key abstracts on GI cancers that were featured at the 2024 ASCO Gastrointestinal Cancers Symposium, including SKYSCRAPER-08, EMERALD-1, and NEST-1 in esophageal squamous cell carcinoma, hepatocellular carcinoma, and colorectal cancer, re ... Show More
22m 45s
Feb 2024
Darmkrebsvorsorge: Die Koloskopie auf dem Prüfstand
mit Prof. Dr. Frank Kolligs, Experte für Gastroenterologie und Endoskopie Seit 2002 wird in Deutschland auf Darmkrebs gescreent, seit 2019 wird darüber auch per Einladungsschreiben informiert und auf diese Vorsorgemöglichkeit aufmerksam gemacht. In Deutschland können Männer ab 50 ... Show More
27m 47s
May 2024
Exploring CAR T Cells in GI Cancers at ASCO24
Dr. Shaalan Beg and Dr.Mohamed Salem discuss key abstracts that will be presented at the 2024 ASCO Annual Meeting, including hypoxia-response CAR T- cell therapy for solid tumors, GPC3-specific CAR T- cell therapy in hepatocellular carcinoma, and the promising efficacy of targete ... Show More
17m 58s
Apr 2024
How ctDNA Is Advancing Care for Patients With GI Cancers
Drs. Shaalan Beg and Aparna Parikh discuss the role of ctDNA as a powerful prognostic biomarker for GI cancers, along with its impact on risk stratification and the detection of recurrence. They highlight key studies in ctDNA that were featured at the 2024 ASCO GI Cancers Symposi ... Show More
17m 21s
Apr 2024
A Revolution in Immunotherapy for Cervical and Endometrial Cancers
Doctors James Ferriss, Linda Duska, and Jayanthi Lea discuss the promise and the challenges of targeting the immune system with immune checkpoint inhibitors, or ICIs, in cervical and endometrial cancers. They also examine emerging data that support the use of ICIs in recurrent ce ... Show More
26m 18s
Oct 2022
Treatment of Metastatic Colorectal Cancer Guideline
An interview with Dr. Van Morris from The University of Texas MD Anderson Cancer Center in Houston, TX and Dr. Cathy Eng from Vanderbilt-Ingram Cancer Center in Nashville, TN, co-chairs on "Treatment of Metastatic Colorectal Cancer: ASCO Guideline." Dr. Morris and Dr. Eng review ... Show More
21m 12s
Apr 2024
Esophageal Cancer Diagnosis and Care for the Primary Care Provider
Host: Darryl S. Chutka, M.D., [@chutkaMD] Guest: Tanios S. Bekaii-Saab, M.D. Although esophageal cancer is not a common malignancy, when found it often has a poor prognosis. It’s about four times more likely to occur in a male than a female. Although a variety of malignancies can ... Show More
27m 4s
May 2024
Cholestase: Knifflige Diagnosen und neue Therapien
Prof. Markus Lerch, München, im Gespräch mit Prof. Verena Keitel-Anselmino, Magdeburg In der Diagnostik und Therapie häufiger cholestatischer Erkrankungen, wie der primär biliären Cholangitis, hat sich die letzten Jahre einiges getan. Und auch bei Seltenheiten gibt es Neues zu be ... Show More
34m 4s